User Auth Test Page

Delta Variant Supplants Beta In South Africa, Study Shows

Bloomberg (9/25, Sguazzin) reported, “The more infectious nature of the delta mutation of the coronavirus has seen it almost completely displace the beta variant in South Africa, the discovery of which led to widespread travel bans.” A study, “released by...

Full Article
Saline Solution Could Slow SARS-CoV-2’s Spread In The Lungs, Study Indicates

HealthDay (9/24, Reinberg) reported that in a “study, a saline solution of sodium chloride at 1.1% reduced replication of the” SARS-CoV-2 “virus by 88% in tests of infected lung cells in the laboratory.” The research was published online in ACS Pharmacolo...

Full Article
Medicare, Medicaid, CHIP To Cover Cost Of COVID-19 Vaccine Boosters For Nearly All Recipients

Bloomberg Law (9/24, Pugh, Subscription Publication) reported, “Medicare, Medicaid, and the Children’s Health Insurance program will pay the full cost of Covid-19 booster shots with no cost-sharing for nearly all beneficiaries, the Biden administration an...

Full Article
CDC Director Overrules Advisory Panel To Broaden Recommended Use Of Pfizer-BioNTech COVID-19 Vaccine Booster Shots For Frontline Workers

The New York Times (9/23, Mandavilli, Mueller) reports that on Friday, CDC Director Dr. Rochelle Walensky “overruled a recommendation by an agency advisory panel that had refused to endorse booster shots of the Pfizer-BioNTech Covid vaccine for frontline...

Full Article
Valneva Expands Trials Of Its COVID-19 Vaccine Candidate, Remains In Talks With European Commission Over Potential Contract

Reuters (9/23, Kar-Gupta, Van Overstraeten, Smout) reports, “Valneva is expanding trials of a COVID-19 vaccine candidate called VLA2001, and remains in talks with the European Commission over a potential contract, the company said on Thursday.” The French...

Full Article
Cutting-Edge Lung Scans Shed Light On “Long COVID” Effects

Reuters (9/23, Younis) reports, “Doctors in California are using cutting-edge lung scans to better understand the effects of ‘long COVID’ among patients who suffer severe symptoms months after their initial bout of infection.” The founder and chief execut...

Full Article
Daily Average Of First Vaccine Doses In US Has Plummeted

The Washington Post (9/23, Jeong) reports that “the number of Americans receiving their first dose of a coronavirus vaccine has dropped significantly in recent days, according to Centers for Disease Control and Prevention data released late Wednesday, wor...

Full Article
Investigators Look At Factors Associated With Septic Shock Among Adult Candidemia Patients

Infectious Disease Advisor (9/23) reports, “More than a quarter of adult patients with chronic liver disease admitted to the intensive care unit (ICU) for treatment of candidemia developed septic shock, according to results of a retrospective observationa...

Full Article
Study Suggests Value In Adding Gentamicin To Patients With Septic Shock

Infectious Disease Advisor (9/23) reports, “Adding gentamicin to empiric antibiotic treatment regimens of patients with septic shock admitted to the intensive care unit (ICU) would have prevented inappropriate antibiotic treatment in 55% of cases, accordi...

Full Article
WHO Updates Recommendations For Monoclonal Antibody Treatment For COVID-19

Healio (9/23) reports, “A WHO guideline panel has updated recommendations for monoclonal antibody treatment in its ‘living’ guide on drugs for COVID-19.” The panel is now recommending “a combination of casirivimab and imdevimab (REGEN-COV; Regeneron) for...

Full Article
WPost Analysis: Experts Not Satisfied With Biden’s 1.1B COVID-19 Vaccine Dose Donation Pledge

The Washington Post (9/23, Taylor) says in an analysis that one of President Biden’s “goals, according to the White House, is to have 70 percent of the world’s population fully vaccinated by this time next year.” In order “to reach it, the United States w...

Full Article
Your Doctor, the Pathologist, Will See You Now

Abstract Not Available

Full Article
Broadening the Scope: A Qualitative Study of Pathologists’ Attitudes Toward Patient-Pathologist Interactions

Abstract Not Available

Full Article
Turning Untested Efforts into Success

Abstract Not Available

Full Article
President Biden Announces Purchase Of 500M Additional COVID-19 Vaccine Doses, Urges World Leaders To Join Fight To Beat The Coronavirus

The New York Times (9/22, Stolberg) reports, “Declaring ‘we need to go big,’ President Biden on Wednesday called on other world leaders, pharmaceutical executives, philanthropists and civil society organizations to band together to forge a global consensu...

Full Article
Strains Of Mutated Plasmodium Falciparum Found In New Region In Africa, Researchers Confirm

MedPage Today (9/22, Gever) reports, “Strains of Plasmodium falciparum carrying mutations that help the malaria-causing parasite to survive treatment with artemisinin compounds have been confirmed in a new region within Africa, adding to mounting concern...

Full Article
Majority Of Patients With Rare COVID-19-Related Inflammatory Disease Admitted To ICU

The Hill (9/22, Beals) reports, “Over half of the adults who developed a rare inflammatory syndrome connected to COVID-19 were treated with serious symptoms in intensive care units, Centers for Disease Control and Prevention researchers found.” A total of...

Full Article
Moderna’s COVID-19 Vaccine Shown To Be Slightly More Protective Than Pfizer’s

The New York Times (9/22, Mandavilli) reports that according to a “half-dozen studies published over the past few weeks, Moderna’s vaccine appeared to be more protective over the long term than the Pfizer-BioNTech vaccine.” CDC data published Friday “foun...

Full Article
Clover Biopharmaceuticals’ COVID-19 Vaccine 67% Effective In Large Trial

Reuters (9/22, Liu, Woo) reports, “A potential COVID-19 vaccine from China’s Clover Biopharmaceuticals was 67% effective against COVID-19 of any degree of severity and 79% against the highly infectious Delta variant in a large trial, the company said on W...

Full Article
Remdesivir Found To Reduce Hospitalization Of Patients With COVID-19 By 87%

Bloomberg (9/22, Gale) reports, “Early treatment with Gilead Sciences Inc.’s remdesivir kept high-risk Covid-19 patients out of the hospital in a late-stage international trial that supports administering the medicine to individuals recovering at home.” A...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Delta Variant Supplants Beta In South Africa, Study Shows

Saline Solution Could Slow SARS-CoV-2’s Spread In The Lungs, Study Indicates

Medicare, Medicaid, CHIP To Cover Cost Of COVID-19 Vaccine Boosters For Nearly All Recipients

CDC Director Overrules Advisory Panel To Broaden Recommended Use Of Pfizer-BioNTech COVID-19 Vaccine Booster Shots For Frontline Workers

Valneva Expands Trials Of Its COVID-19 Vaccine Candidate, Remains In Talks With European Commission Over Potential Contract

Cutting-Edge Lung Scans Shed Light On “Long COVID” Effects

Daily Average Of First Vaccine Doses In US Has Plummeted

Investigators Look At Factors Associated With Septic Shock Among Adult Candidemia Patients

Study Suggests Value In Adding Gentamicin To Patients With Septic Shock

WHO Updates Recommendations For Monoclonal Antibody Treatment For COVID-19

WPost Analysis: Experts Not Satisfied With Biden’s 1.1B COVID-19 Vaccine Dose Donation Pledge

Your Doctor, the Pathologist, Will See You Now

Broadening the Scope: A Qualitative Study of Pathologists’ Attitudes Toward Patient-Pathologist Interactions

Turning Untested Efforts into Success

President Biden Announces Purchase Of 500M Additional COVID-19 Vaccine Doses, Urges World Leaders To Join Fight To Beat The Coronavirus

Strains Of Mutated Plasmodium Falciparum Found In New Region In Africa, Researchers Confirm

Majority Of Patients With Rare COVID-19-Related Inflammatory Disease Admitted To ICU

Moderna’s COVID-19 Vaccine Shown To Be Slightly More Protective Than Pfizer’s

Clover Biopharmaceuticals’ COVID-19 Vaccine 67% Effective In Large Trial

Remdesivir Found To Reduce Hospitalization Of Patients With COVID-19 By 87%